Study on Novel Strategies for Cervical Cancer Screening Using Photoelectric Detection and Epigenetic Procotol

Inclusion Criteria: 1. Women between the ages of 18 and 65 who have already had sex life 2. HPV16, 18 positive or high-risk HPV infection with cytology ≧ASC-US 3. No history of cervical cancer and cervical physical therapy, a complete cervix 4. No menstrual period, no sexual activity and vaginal medication within 48 hours 5. The vagina or cervix is not in a stage of acute inflammation 6. Willing to participate in the study with full informed consent Exclusion Criteria: 1. Cervical dysplasia (congenital malformation or double uterus, etc.) 2. History of cervical treatment (coning, ablation, or photodynamic therapy) 3. There are definite immunosuppression conditions, such as HIV infection or organ transplantation 4. Patients with severe bleeding diseases such as coagulation abnormalities or photosensitive diseases (such as porphyria, lupus erythematosus, etc.) 5. A history of radiation or chemotherapy (e.g., pelvic radiation therapy) with cancer at other sites 6. The patient is in pregnancy or puerperium 7. The other conditions of this study were not considered appropriate by the researchers